首页> 美国卫生研究院文献>The Oncologist >Tolerability Efficacy and Safety of Pegylated Liposomal Doxorubicin in Combination with Carboplatin Versus Gemcitabine–Carboplatin for the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer: A Systematic Review

【2h】

Tolerability Efficacy and Safety of Pegylated Liposomal Doxorubicin in Combination with Carboplatin Versus Gemcitabine–Carboplatin for the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer: A Systematic Review

机译：聚乙二醇化脂质体阿霉素联合卡铂与吉西他滨-卡铂联合治疗铂敏感性复发性卵巢癌的耐受性功效和安全性：系统评价

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective.To compare the tolerability, efficacy, and safety profiles of pegylated liposomal doxorubicin in combination with carboplatin (PLD–Carbo) with those of gemcitabine–carboplatin (Gem–Carbo) for the treatment of patients with platinum-sensitive recurrent ovarian cancer (PSROC) by reviewing the published literature.

机译：目的：比较聚乙二醇化脂质体阿霉素联合卡铂（PLD-Carbo）和吉西他滨-卡铂（Gem-Carbo）治疗铂敏感性复发性卵巢癌（PSROC）的耐受性，疗效和安全性），以查看已发表的文献。

著录项

期刊名称 The Oncologist
作者
Robert W. Holloway; Edward C. Grendys; Patrick Lefebvre; Francis Vekeman; Scott McMeekin;
展开▼
作者单位

展开▼
年(卷),期 2010(15),10
年度 2010
页码 1073–1082
总页数 10
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
Ovarian cancer Platinum Pegylated liposomal doxorubicin Gemcitabine Carboplatin;

机译：卵巢癌;铂;聚乙二醇脂质体阿霉素;吉西他滨;卡铂;

相似文献

外文文献
中文文献
专利

1. Tolerability, efficacy, and safety of pegylated liposomal Doxorubicin in combination with Carboplatin versus gemcitabine-Carboplatin for the treatment of platinum-sensitive recurrent ovarian cancer: a systematic review. [J] . Holloway RW, Grendys EC, Lefebvre P, The oncologist . 2010,第10期

机译：聚乙二醇化脂质体阿霉素联合卡铂与吉西他滨-卡铂联合治疗铂敏感型复发性卵巢癌的耐受性，疗效和安全性：系统评价。
2. Tolerability, Efficacy, and Safety of Pegylated Liposomal Doxorubicin in Combination with Carboplatin Versus Gemcitabine–Carboplatin for the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer: A Systematic Review [J] . Edward C. Grendys, Francis Vekeman, Patrick Lefebvre, The oncologist . 2010,第10期

机译：聚乙二醇化脂质体阿霉素联合卡铂与吉西他滨-卡铂联合治疗铂敏感性复发性卵巢癌的耐受性，功效和安全性：系统评价
3. A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study) [J] . Fujiwara Hiroyuki, Ushijima Kimio, Nagao Shoji, International journal of clinical oncology . 2019,第10期

机译：二乙烯基化脂质体多菱霉素和卡铂与吉西他滨与铂敏感性复发性卵巢癌（GOTIC003 / INCOROUP研究）的II期随机对照研究
4. PHASE III COMPARISON OF CARBOPLATIN VERSUS CARBOPLATIN AND DOXORUBICIN FOR THE ADJUVANT TREATMENT OF APPENDICULAR OSTEOSARCOMA: INTERIM ANALYSIS [C] . Katherine Skorupski, Justin Uhl, Stephen Shaw, Annual Conference of the Veterinary Cancer Society . 2009

机译：Carboplatin与Carboplatin和多柔比星的相位III比较，用于辅助骨肉瘤的佐剂治疗：临时分析
5. The Use Of Carboplatin and Cyclosporin A In The Treatment of Recurrent Epithelial Ovarian Cancer. [D] . Overton, Eve. 2016

机译：卡铂和环孢菌素A在复发性上皮性卵巢癌治疗中的应用。
6. Retrospective Analysis Of Comparative Outcomes In Recurrent Platinum-Sensitive Ovarian Cancer Treated With Pegylated Liposomal Doxorubicin (Lipo-Dox) And Carboplatin Versus Paclitaxel And Carboplatin [O] . Chia-Sui Weng, Chao-Chih Wu, Tze-Chien Chen, 2019

机译：聚乙二醇化脂质体阿霉素（Lipo-Dox）和卡铂与紫杉醇和卡铂治疗复发的铂敏感性卵巢癌的比较结果的回顾性分析
7. Tolerability, Efficacy, and Safety of Pegylated Liposomal Doxorubicin in Combination with Carboplatin Versus Gemcitabine–Carboplatin for the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer: A Systematic Review [O] . Holloway, Robert W., Grendys, Edward C., Lefebvre, Patrick, 2010

机译：聚乙二醇化脂质体阿霉素联合卡铂与吉西他滨-卡铂联合治疗铂敏感性复发性卵巢癌的耐受性，功效和安全性：系统评价

Tolerability Efficacy and Safety of Pegylated Liposomal Doxorubicin in Combination with Carboplatin Versus Gemcitabine–Carboplatin for the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer: A Systematic Review

摘要

著录项

相似文献

相关主题

期刊订阅